Histologic features relating to prognosis in synovial sarcoma

Leslie A. Cagle; Joseph M. Mirra; F. Kristian Storm; Denise J. Roe; Frederick R. Eilber

doi:10.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R

Histologic features relating to prognosis in synovial sarcoma

Leslie A. Cagle, Joseph M. Mirra, F. Kristian Storm, Denise J. Roe, Frederick R. Eilber

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Abstract

Although the American Joint Commission has classified all synovial sarcomas as “high grade” histologic subtypes can be identified. By histologically subclassifying synovial sarcoma tumors according to percent glandularity and mitotic rates, the authors were able to define high‐risk and low‐risk patients. Charts and original pathologic slides were reviewed on 45 synovial sarcoma patients. With a 41‐month median follow‐up, the low‐risk patients showed 100% survival, whereas the high‐risk patients showed 37% survival.

Original language	English (US)
Pages (from-to)	1810-1814
Number of pages	5
Journal	Cancer
Volume	59
Issue number	10
DOIs	https://doi.org/10.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R
State	Published - May 15 1987
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R

Fingerprint Dive into the research topics of 'Histologic features relating to prognosis in synovial sarcoma'. Together they form a unique fingerprint.

Cite this

@article{eaff1c9654df4f2f86aa7c1ef538103c,

title = "Histologic features relating to prognosis in synovial sarcoma",

abstract = "Although the American Joint Commission has classified all synovial sarcomas as “high grade” histologic subtypes can be identified. By histologically subclassifying synovial sarcoma tumors according to percent glandularity and mitotic rates, the authors were able to define high‐risk and low‐risk patients. Charts and original pathologic slides were reviewed on 45 synovial sarcoma patients. With a 41‐month median follow‐up, the low‐risk patients showed 100% survival, whereas the high‐risk patients showed 37% survival.",

author = "Cagle, {Leslie A.} and Mirra, {Joseph M.} and Storm, {F. Kristian} and Roe, {Denise J.} and Eilber, {Frederick R.}",

year = "1987",

month = may,

day = "15",

doi = "10.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R",

language = "English (US)",

volume = "59",

pages = "1810--1814",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - Histologic features relating to prognosis in synovial sarcoma

AU - Cagle, Leslie A.

AU - Mirra, Joseph M.

AU - Storm, F. Kristian

AU - Roe, Denise J.

AU - Eilber, Frederick R.

PY - 1987/5/15

Y1 - 1987/5/15

N2 - Although the American Joint Commission has classified all synovial sarcomas as “high grade” histologic subtypes can be identified. By histologically subclassifying synovial sarcoma tumors according to percent glandularity and mitotic rates, the authors were able to define high‐risk and low‐risk patients. Charts and original pathologic slides were reviewed on 45 synovial sarcoma patients. With a 41‐month median follow‐up, the low‐risk patients showed 100% survival, whereas the high‐risk patients showed 37% survival.

AB - Although the American Joint Commission has classified all synovial sarcomas as “high grade” histologic subtypes can be identified. By histologically subclassifying synovial sarcoma tumors according to percent glandularity and mitotic rates, the authors were able to define high‐risk and low‐risk patients. Charts and original pathologic slides were reviewed on 45 synovial sarcoma patients. With a 41‐month median follow‐up, the low‐risk patients showed 100% survival, whereas the high‐risk patients showed 37% survival.

UR - http://www.scopus.com/inward/record.url?scp=0023267846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023267846&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R

DO - 10.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R

M3 - Article

C2 - 3828949

AN - SCOPUS:0023267846

VL - 59

SP - 1810

EP - 1814

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10

ER -

Histologic features relating to prognosis in synovial sarcoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this